NATH BIOGENES (INDIA)
|
NATH BIOGENES (INDIA) Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹41 Cr | ₹42 Cr | ₹36 Cr | ₹-63 Cr | ₹12 Cr |
| Adjustment | ₹13 Cr | ₹10 Cr | ₹13 Cr | ₹102 Cr | ₹8.18 Cr |
| Changes In working Capital | ₹-35 Cr | ₹23 Cr | ₹-9.81 Cr | ₹-19 Cr | ₹-5.72 Cr |
| Cash Flow after changes in Working Capital | ₹19 Cr | ₹75 Cr | ₹39 Cr | ₹20 Cr | ₹15 Cr |
| Cash Flow from Operating Activities | ₹18 Cr | ₹75 Cr | ₹38 Cr | ₹17 Cr | ₹14 Cr |
| Cash Flow from Investing Activities | ₹-3.96 Cr | ₹-27 Cr | ₹-2.88 Cr | ₹-20 Cr | ₹-21 Cr |
| Cash Flow from Financing Activities | ₹-2.13 Cr | ₹-7.78 Cr | ₹-1.67 Cr | ₹-22 Cr | ₹5.74 Cr |
| Net Cash Inflow / Outflow | ₹11 Cr | ₹39 Cr | ₹34 Cr | ₹-25 Cr | ₹-0.81 Cr |
| Opening Cash & Cash Equivalents | ₹77 Cr | ₹38 Cr | ₹4.18 Cr | ₹29 Cr | ₹3.29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹89 Cr | ₹77 Cr | ₹38 Cr | ₹4.18 Cr | ₹2.48 Cr |
Compare Cashflow Statement of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹372.4 Cr | 15.3% | 51.2% | 8.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,472.1 Cr | 0.3% | 9.1% | -20.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,960.0 Cr | 2.5% | 21.8% | -35.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,232.1 Cr | 4.4% | 30.5% | -7.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,033.1 Cr | -3.6% | 46.1% | -27.8% | Stock Analytics | |
| INDO US BIOTECH | ₹210.6 Cr | 2.5% | 4.9% | -39.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 15.3% |
51.2% |
8.9% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses